During the 15th Annual Meeting of the Japanese Society for Regenerative Medicine in Osaka, Tsutumu Tomioka, Vice Minister of MEXT, deplored the relative decrease of Japan’s national expenditures on R&D by 1 % per year and hinted on future additional investments on targets such as robotics, big data, AI and regenerative medicine, which might include a commitment to construct a National Center for Regenerative Medicine.

Nikkei Biotech, March 18, 2016